Menu Search
Equities

Medinet Co Ltd

2370:TYO

Medinet Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)45.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.00m
  • 1 Year change-10.00%
  • Beta2.2180
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Medinet Co Ltd's net income fell 14.66% from a loss of 1.25bn to a larger loss of 1.44bn despite revenues that grew 4.40% from 633.67m to 661.54m. An increase in the selling, general and administrative costs as a percentage of sales from 135.45% to 150.33% was a component in the falling net income despite rising revenues.
Gross margin17.78%
Net profit margin-177.09%
Operating margin-183.41%
Return on assets-23.85%
Return on equity-26.38%
Return on investment-24.99%
More ▼

Cash flow in JPYView more

In 2023, Medinet Co Ltd did not generate a significant amount of cash. Cash Flow from Financing totalled 1.16bn or 175.00% of revenues. In addition the company used 1.26bn for operations while cash from investing totalled 3.27m.
Cash flow per share-5.04
Price/Cash flow per share--
Book value per share20.31
Tangible book value per share19.90
More ▼

Balance sheet in JPYView more

Medinet Co Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio19.09
Quick ratio18.90
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.